Cite
Krentz AJ, Honigsberger L, Ellis SH, et al. A 12-month randomized controlled study of the aldose reductase inhibitor ponalrestat in patients with chronic symptomatic diabetic neuropathy. Diabet Med. 1992;9(5):463-8doi: 10.1111/j.1464-5491.1992.tb01818.x.
Krentz, A. J., Honigsberger, L., Ellis, S. H., Hardman, M., & Nattrass, M. (1992). A 12-month randomized controlled study of the aldose reductase inhibitor ponalrestat in patients with chronic symptomatic diabetic neuropathy. Diabetic medicine : a journal of the British Diabetic Association, 9(5), 463-8. https://doi.org/10.1111/j.1464-5491.1992.tb01818.x
Krentz, A J, et al. "A 12-month randomized controlled study of the aldose reductase inhibitor ponalrestat in patients with chronic symptomatic diabetic neuropathy." Diabetic medicine : a journal of the British Diabetic Association vol. 9,5 (1992): 463-8. doi: https://doi.org/10.1111/j.1464-5491.1992.tb01818.x
Krentz AJ, Honigsberger L, Ellis SH, Hardman M, Nattrass M. A 12-month randomized controlled study of the aldose reductase inhibitor ponalrestat in patients with chronic symptomatic diabetic neuropathy. Diabet Med. 1992 Jun;9(5):463-8. doi: 10.1111/j.1464-5491.1992.tb01818.x. PMID: 1611835.
Copy
Download .nbib